Evidence map›Paper›PMID 34783630›Full record

ArticlePathogens and global health2022

Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.

Zia Ul Mustafa, Muhammad Salman Saleem, Muhammad Nabeel Ikram, Muhammad Salman, Sanan Amjad Butt, Shehroze Khan, Brian Godman, R Andrew Seaton

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Pathogens and global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Zia Ul MustafaDepartment of Pharmacy Services, District Headquarter Hospital Pakpattan, Pakpattan, Pakistan.ORCID 0000-0002-8109-4859
Muhammad Salman SaleemDepartment of Surgery, Faisalabad Medical University, Faisalabad, Pakistan.
Muhammad Nabeel IkramDepartment of Surgery, Faisalabad Medical University, Faisalabad, Pakistan.
Muhammad SalmanDepartment of Pharmacy, The University of Lahore, Lahore, Pakistan.ORCID 0000-0002-4366-1461
Sanan Amjad ButtCollege of Pharmacy, University of Sargodha, Sargodha, Pakistan.
Shehroze KhanPunjab University College of Pharmacy, University of the Punjab, Lahore Pakistan.
Brian GodmanStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
R Andrew SeatonQueen Elizabeth University Hospital, Glasgow, UK.
Punjab Medical College · PKHealthcare Improvement Scotland · GBUniversiti Sains Malaysia · MYUniversity of Lahore · PKUniversity of Sargodha · PKUniversity of the Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are reports of high rates of antibiotic prescribing among hospitalized patients with COVID-19 around the world. To date, however, there are few reports of prescribing in relation to COVID-19 in Pakistan. Herein, we describe a point prevalence survey of antibiotic prescribing amongst patients hospitalized with suspected or proven COVID-19 in Pakistan. A Point Prevalence Survey (PPS) was undertaken in seven tertiary care health facilities in Punjab Provence, Pakistan. Baseline information about antimicrobial use according to the World Health Organization (WHO) standardized methodology was collected on a single day between 5

Indexed as

Anti-Infective AgentsBacterial InfectionsCoinfectionCOVID-19COVID-19 Drug TreatmentAdultAnti-Bacterial AgentsAzithromycinCeftriaxoneDrug PrescriptionsFemaleHumansMaleMeropenemPakistanPrevalenceAnti-Bacterial AgentsAnti-Infective AgentsAzithromycinCeftriaxoneMeropenemantimicrobialCovid-19HospitalizedPakistanPunjabsurveillanceuse

Identifiers

PMID34783630
PMCPMC9518253
OpenAlexW3209032723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.